Abstract
Prior to this decade, routine antibiotic-susceptibility testing (AST) of Mycobacterium tuberculosis clinical isolates was not advocated (1) This policy was predicated on the following assumptions:
-
1.
The prevalence ofantibiotic resistance is low, occurring primarily among patients previously treated for tuberculosis (TB) who have relapsed,
-
2.
Tuberculous infection progresses slowly, so that resistant strains of M tuberctlosis can be treated empirically with sequential therapeutic regimens without incurring great risks; and
-
3
The long delay before AST information is available (6–12 wk) precludes a practical impact on patient care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Heifets, L B (1991) Drug Susceptibility in the Chemotherapy of Mycobacterial Infections CRC, Boca Raton, FL, pp 1–57.
Frieden, T. R, Sterling, T, Pablos-Mendez, A, Kilburn, J. O, Cauthen, G M., and Dooley, S W. (1993) The emergence of drug-resistant tuberculosis in New York City. N. Engl J Med 328, 521–526
Bloch, A B, Cauthen, G M., Onorato, I M, Dansbury, K. G, Kelly, G D, Drover, C. R, and Snider, D E, Jr. (1994) Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 271, 665–671
Cohn, D L., Bustreo, F., and Raviglione, M C. (1997) Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. Clin Inf Dis. 24, S121–S130.
Shafer, R. W, Small, P. M, Larkm, C, Singh, S P., Kelly, P, Sierra, M. F., Schoolnik, G., and Chirgwm, K. D. (1995) Temporal trends and transmission patterns during the emergence of multidrug-resistant tuberculosis in New York City. A molecular epidemiologic assessment. J inf. Dis 171, 170–176
Iseman, M. D. (1993) Treatment of multidrug-resistant tuberculosis. N Engl J Med 329, 784–791
Daley, C. L, Small, P M, Schecter, G. F, Schoolnik, G K., McAdam, R. A., Jacobs, W. R., Jr., and Hopewell, P C. (1992) An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restrictton-fragment-length polymorphism. N Engl. J. Med. 326, 231–235
Pablos-Mendez, A, Sterling, T R., and Frieden, T. R (1996) The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA 276, 1223–1228
Turett, G. S., Telzak, E. E., Torian, L. V., Blum, S, Alland, D., Weisfuse, I., and Fazal, B. A (1995) Improved outcomes for patients with multidrug-resistant tuberculosis Clin inf Dis 21, 1238–1244.
Menzies, D., Fanning, A, Yuan, L, and Fitzgerald, M (1995) Tuberculosis among health care workers N Engl J Med 332, 92–98.
Tokars, J. I., Rudnick, J., Kroc, K., Manangan, L., Pughese, G, Huebner, R. E., Chan, J., and Jarvis, W. R. (1996) US hospital mycobacteriology laboratories status and comparison with state public health department laboratories J Clin Microbiol. 34, 680–685
Anonymous (1993) Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis [published erratum appears in MMWR Morb Mortal Wkly Rep 1993 Jul 26;42(27)536]. MMWR—Morbldlty, and Mortal@ Weekly Report 42, 1–8
Anonymous (1992) Meeting the challenge of multidrug-resistant tuberculosis summary of a conference. MMWR—Morbidity, and Mortality Weekly Report 41, 51–57.
Bates, J H (1995) Tuberculosis chemotherapy. the need for new antituberculosis drugs is urgent. Amer J Respir Crit Care Med 151, 942–943
Anonymous (1996) Nucleic acid amplification tests for tuberculosis MMWR— Morbidity, and Mortality Weekly Report 45, 950–952
Telenti, A., Honore, N., Bernascom, C., March, J., Ortega, A, Heym, B, Taklff, H. E., and Cole, S T. (1997) Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level J Clin. Microbiol 35, 719–723.
De Beenhouwer, H., Lhiang, Z, Jannes, G, MIJS, W., Machtelinckx, L, Rossau, R., Traore, H., and Portaels, F. (1995) Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tubercle Lung Dis 76, 425–430
Musser, J M. (1995) Antimicrobial agent resistance in mycobacteria molecular genetic insights. Clin Microblol Rev 8, 496–514
Noordhoek, G. T, Kolk, A H, Bjune, G, Catty, D, Dale, J W, Fine, P E, Godfrey-Faussett, P, Cho, S N., Shmnick, T., Svenson, S B., Wilson, S, and van
Embden, J. D. A (1994) Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol 32, 277–284
Hellyer, T.J., Fletcher, T.W, Bates, J H., Stead, W W., Templeton, G L, Cave, M. D., and Eisenach, K D. (1996) Strand displacement amplification and the polymerase chain reaction for monitoring response to treatment in patients with pulmonary tuberculosis. J Infect Dis 173, 934–941.
Yajko, D. M, Madej, J. J, Lancaster, M. V., Sanders, C. A, Cawthon, V L, Gee, B., Babst, A., and Hadley, W K (1995) Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis J Clin Microbiol 33, 2324–2327.
Nilsson, L E, Hoffner, S E, and Ansehn, S (1988) Rapid susceptibility testing ofMycobacterium tuberculosis by biolummescence assay of mycobacterial ATP Antimicrob. Agents Chemother 32, 1208–1212.
Mizuguchi, Y. (1984) Mycobacteriophages, in The Mycobacteria. A Sourcebook (part A) (Kubica, G. P. and Wayne, L. G, eds.), Marcel Dekker, New York, pp. 641–662
Hatfull, G F. and Jacobs, W. R, Jr. (1994) Mycobacteriophages cornerstones of mycobacterial research, in Tuberculosis Pathogenesis, Protection and Control (Bloom, B R., ed.), ASM, Washington, DC, pp. 165–183
Jacobs, W. R., Jr., Barletta, R. G, Udani, R., Chan, J., Kalkut, G., Sosne, G., Kieser, T., Sarkis, G J., Hatfull, G F, and Bloom, B R (1993) Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 260, 819–822.
Andrew, P. W. and Roberts, I. S. (1993) Construction of a bioluminescent mycobacterium and its use for assay of antimycobacterial agents. J. Clin Microbial. 31, 2251–2254
Pearson, R. E., Jurgenson, S., Sarkis, G. J., Hatfull, G. F., and Jacobs, W. R., Jr. (1996) Construction of D29 shuttle phasmids and luciferase reporter phages for detection of mycobacteria Gene 183, 129–136
Sarkrs, G. J, Jacobs, W. R., Jr, and Hatfull, G. F. (1995) L5 luciferase reporter mycobacteriophages a sensitive tool for the detection and assay of live mycobacteria Mol Microbial. 15, 1055–1067
De Wet, J. R, Wood, K V., DeLuca, M., Helinslu, D. R., and Subramani, S. (1987) Firefly lucifemse gene: structure and expression in mammalian cells. Mol Cell. Biol 7, 725–737
Luciferuse Assay Guide Book (1992) Analytical Luminescence Laboratories, San Diego, CA.
Matamoras, M. C and Strobl, J. S (1990) Detection of gene promoter activity in mammalian cells using the firefly luciferase reporter gene, in Luminescence Immunoassays and Molecular Applications (Van Dyke, K and Van Dyke, R., eds.), CRC, Boca Raton, FL, pp. 311–319
Bronstein, I., Fortin, J., Stanley, P. E., Stewart, G. S., and Kncka, L. J. (1994) Chemiluminescent and bioluminescent reporter gene assays. Anal. Biochem. 219, 169–181.
Ulitzer, S. and Kuhn, J. (1987) Introduction of lux genes into bacteria: a new approach for specific determinants of bacteria and their antibiotic susceptibilities, in Bioluminescence and Chemiluminescence. New Perspectives (Sclomerick, J., Andersen, R. R., Kapp, A, Ernst, M., and Woods W. G, eds.), John Wiley, and Sons, New York, pp. 463–472.
Timme, T L. and Brennan, P. J. (1984) Induction of bacteriophage from members of the Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium scrofulaceum serocomplex J Gen. Microbiol 130, 2059–2066.
Riska, P. F., Jacobs, W. R., Jr., Bloom, B. R., McKitrick, J., and Chan, J. (1997) Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of para-nitro-alpha-acetylamino-beta-hydroxy-proplophenone J Clin. Macro., in press.
Arain, T M., Resconi, A., Hickey, M. J., and Stover, C. K. (1996) Bioluminescence Screening In Vitro (Bio-Siv) Assays for high-volume antimycobacterial drug discovery Antimicrob Agents Chemother 40, 1536–1541
Cooksey, R. C., Crawford, J. T., Jacobs, W. R., Jr, and Shinnick, T M. (1993) A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase. Antimicrob Agent Chemother 37, 1348–1352.
Cooksey, R C., Morlock, G. P, Beggs, M., and Crawford, J. T. (1995) Broluminescence method to evaluate antimicrobial agents against Mycobacterium avium Antimicrob Agents Chemother 39, 754–756.
Shawar, R. M., Humble, D. J., Van Dalfsen, J. M, Stover, C. K, Hockey, M J., Steele S., Mitscher, L. A., and Baker, W (1997) Rapid screening of natural products for antimycobacterial activity by using luciferase-expressing strains of Mycobacterium bovis BCG and Mycobacterium intracellulare. Antimicrob Agents Chemother 41, 570–574.
Arain, T. M., Resconi, A. E., Singh, D C., and Stover, C K. (1996) Reporter gene technology to assess activity of antimycobacterial agents in macrophages Antimicrob Agents Chemother 40, 1542–1544.
Hickey, M. J, Aram, T. M., Shawar, R. M., Humble, D. J., Langhorne, M H, Morgenroth, J. N, and Stover, C K (1996) Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice. Antimicrob. Agents Chemother. 40, 400–407.
Riska, P. F., Cohen, M. A., Gracheck, S. J., Renau, T. E., and Jacobs, W R., Jr. (1995) The mycobacterial luciferase reporter phage as a tool for rapid screening of novel antimycobacterial agents. Programs and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy San Francisco, CA (abstract).
Riska, P. F., Jacobs, W. R., Jr., Bloom, B. R., and Chan, J. (1996) Rapid determination of Antibiotic Susceptibility patterns of Mycobacterium tuberculosis samples using the luciferase reporter phage assay. 7th International Congress for Infectious Diseases Hong Kong (abstract)
Carriére, C., Riska, P. F., Zimbony, O., Kriakov, J., Bardarov, S., Bums, J., Chan, J., and Jacobs, W. R., Jr. (1997) Conditionally replicating luciferase reporter phages improved sensitivity for rapid detection and assessment of drug susceptibility of Mycobacterium tuberculosis. J. Clin Microbial in press.
Snapper, S B, Melton, R E, Mustafa, S, Kieser, T., and Jacobs, W. R, Jr (1990) Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol. Microbtol. 4, 1911–1919.
Biosafety in Microbioiogical and Biomedical Laboratories (1988) US Dept of Health and Human Services, Washington, DC.
Siddiqi, S. H. (1995) BACTEC TB Product and Procedure Manual (Rev. D) Becton Dickmson, Sparks, MD.
Product and User′s Manual (MA-0092): BACTEC 9000MB System. (1995) Becton Dickinson Diagnostic Instrument Systems, Sparks, MD
Kent, P. T. and Kubica, G. P (1985) Public Health Mycobacteriology A guide for the Level III Laboratory Centers for Disease Control, Atlanta, GA.
Yamori, S. and Tsukamura, M (1991) Paradoxical effect of Tween-80 between the susceptibility to rifampicin and streptomycin and the susceptibility to ethambutol and sulfadimethoxine in the Mycobacterium avium-Mycobacterium intracellulare complex. Microbiol Immunol. 35, 921–926.
Heifets, L B. and Good, R. C. (1994) Current laboratory methods for the diagnosis of tuberculosis, in Tuberculosis. Pathogenests, Protection and Control (Bloom, B. R., ed ), ASM, Washington DC, pp 85–110.
Wallace, R. J., Jr., Nash D. R., Steele L. C., and Steingrube V. (1986) Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. J. Clan. Microbtol 24, 976–981.
Canetti, G, Fox, W., Khomenko, A., Mahler, H. T., Menon, N. K., Mitchison, D. A., Rist, N, and Smelev, N A. (1969) Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Org 41, 21–43.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Riska, P.F., Jacobs, W.R. (1998). The Use of Luciferase-Reporter Phage for Antibiotic-Susceptibility Testing of Mycobacteria. In: Parish, T., Stoker, N.G. (eds) Mycobacteria Protocols. Methods in Molecular Biology™, vol 101. Humana Press. https://doi.org/10.1385/0-89603-471-2:431
Download citation
DOI: https://doi.org/10.1385/0-89603-471-2:431
Publisher Name: Humana Press
Print ISBN: 978-0-89603-471-6
Online ISBN: 978-1-59259-576-1
eBook Packages: Springer Protocols